BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18323853)

  • 1. A cancer terminator virus eradicates both primary and distant human melanomas.
    Sarkar D; Su ZZ; Park ES; Vozhilla N; Dent P; Curiel DT; Fisher PB
    Cancer Gene Ther; 2008 May; 15(5):293-302. PubMed ID: 18323853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice.
    Sarkar D; Su ZZ; Vozhilla N; Park ES; Randolph A; Valerie K; Fisher PB
    Cancer Res; 2005 Oct; 65(19):9056-63. PubMed ID: 16204080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.
    Sarkar D; Lebedeva IV; Su ZZ; Park ES; Chatman L; Vozhilla N; Dent P; Curiel DT; Fisher PB
    Cancer Res; 2007 Jun; 67(11):5434-42. PubMed ID: 17545625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
    J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice.
    Sarkar D; Su ZZ; Vozhilla N; Park ES; Gupta P; Fisher PB
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):14034-9. PubMed ID: 16172403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model.
    Melquist JJ; Kacka M; Li Y; Malaeb BS; Elmore J; Baseman AG; Hsieh JT; Koeneman KS
    Urol Oncol; 2006; 24(4):362-71. PubMed ID: 16818192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
    Maemondo M; Saijo Y; Narumi K; Kikuchi T; Usui K; Tazawa R; Matsumoto K; Nakamura T; Sasaki K; Takahashi M; Niitsu Y; Nukiwa T
    Cancer Res; 2004 Jul; 64(13):4611-20. PubMed ID: 15231673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel attenuated replication-competent adenovirus for melanoma therapy.
    Peter I; Graf C; Dummer R; Schaffner W; Greber UF; Hemmi S
    Gene Ther; 2003 Apr; 10(7):530-9. PubMed ID: 12646858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.
    Nettelbeck DM; Rivera AA; Balagué C; Alemany R; Curiel DT
    Cancer Res; 2002 Aug; 62(16):4663-70. PubMed ID: 12183423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy.
    Leja J; Dzojic H; Gustafson E; Oberg K; Giandomenico V; Essand M
    Clin Cancer Res; 2007 Apr; 13(8):2455-62. PubMed ID: 17438105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.
    Kim JH; Lee YS; Kim H; Huang JH; Yoon AR; Yun CO
    J Natl Cancer Inst; 2006 Oct; 98(20):1482-93. PubMed ID: 17047197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting prostate cancer with conditionally replicative adenovirus using PSMA enhancer.
    Lee SJ; Zhang Y; Lee SD; Jung C; Li X; Kim HS; Bae KH; Jeng MH; Kao C; Gardner T
    Mol Ther; 2004 Dec; 10(6):1051-8. PubMed ID: 15564137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.
    Cafferata EG; Macció DR; Lopez MV; Viale DL; Carbone C; Mazzolini G; Podhajcer OL
    Clin Cancer Res; 2009 May; 15(9):3037-49. PubMed ID: 19336523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midkine promoter-based conditionally replicative adenovirus for targeting midkine-expressing human bladder cancer model.
    Terao S; Shirakawa T; Kubo S; Bishunu A; Lee SJ; Goda K; Tsukuda M; Hamada K; Tagawa M; Takenaka A; Fujisawa M; Gotoh A
    Urology; 2007 Nov; 70(5):1009-13. PubMed ID: 17919690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged survival of mice with multiple liver metastases of human colon cancer by intravenous administration of replicable E1B-55K-deleted adenovirus with E1A expressed by CEA promoter.
    Sagawa T; Takahashi M; Sato T; Sato Y; Lu Y; Sumiyoshi T; Yamada Y; Iyama S; Fukaura J; Sasaki K; Hamada H; Miyanishi K; Takayama T; Kato J; Niitsu Y
    Mol Ther; 2004 Dec; 10(6):1043-50. PubMed ID: 15564136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A truncated minimal-E1a gene with potency to support adenoviral replication mediates antitumor activity by down-regulating Neu expression and preserving Rb function.
    Fang L; Huang Y; Hu X; Sun L; He X; Hu H; Pu Y; Cao X; Luo H; Pan S; Gu J; Su C
    Chem Biol Interact; 2009 Sep; 181(1):1-7. PubMed ID: 19523934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel targeting modality to enhance adenoviral replication by vitamin D(3) in androgen-independent human prostate cancer cells and tumors.
    Hsieh CL; Yang L; Miao L; Yeung F; Kao C; Yang H; Zhau HE; Chung LW
    Cancer Res; 2002 Jun; 62(11):3084-92. PubMed ID: 12036918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.
    Greco A; Di Benedetto A; Howard CM; Kelly S; Nande R; Dementieva Y; Miranda M; Brunetti A; Salvatore M; Claudio L; Sarkar D; Dent P; Curiel DT; Fisher PB; Claudio PP
    Mol Ther; 2010 Feb; 18(2):295-306. PubMed ID: 19888195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication-competent CD95L adenovirus.
    Fecker LF; Schmude M; Jost S; Hossini AM; Picó AH; Wang X; Schwarz C; Fechner H; Eberle J
    Exp Dermatol; 2010 Aug; 19(8):e56-66. PubMed ID: 19725869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts.
    Yu DC; Chen Y; Seng M; Dilley J; Henderson DR
    Cancer Res; 1999 Sep; 59(17):4200-3. PubMed ID: 10485454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.